Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 1, 2004, Pages 37-45

  Bersinger, Nick A ^a   Ødegård, Rønnaug A ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Fetal growth restriction; Placenta; Preeclampsia; Pregnancy associated plasma protein A; Serum markers

Indexed keywords

GROWTH FACTOR; HUMAN PLACENTA LACTOGEN; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME IMMUNOASSAY; FEMALE; FETUS GROWTH; GROWTH RETARDATION; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PLACENTAL LACTOGEN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEINS; PROSPECTIVE STUDIES;

EID: 1242266433     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2004.00277.x     Document Type: Article

References (38)

1. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049-59.
2. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996; 175: 1365-70.
3. Austgulen R, Lien E, Vince G, Redman CW. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 71: 53-8.
4. Hefler L, Kainz C, Zeisler H, Heinze G, Schatten C, Husslein P et al. Serum levels of leukocyte functional antigen-3 in pregnancy and preeclampsia. Acta Obstet Gynecol Scand 1999; 78: 580-5.
5. Hefler L, Obermair A, Husslein P, Kainz C, Tempfer C. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia. Acta Obstet Gynecol Scand 2000; 79: 77-8.
6. Ellis J, Wennerholm UB, Bengtsson A, Lilja H, Pettersson A, Sultan B et al. Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 2001; 80: 602-8.
7. Huber A, Hefler L, Tempfer C, Zeisler H, Lebrecht A, Husslein P. Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 2002; 81: 168-71.
8. Oxvig C, Sand O, Kristensen T, Kristensen L, Sottrup-Jensen L. Isolation and characterisation of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim Biophys Acta 1994; 1201: 415-23.
9. Bischof P. Placental proteins: pregnancy-associated plasma protein A (PAPP-A). Contrib Gynecol Obstet 1984; 12: 41-73.
10. Bischof P. Placental proteins: Schwangerschaftsprotein 1 Contrib Gynecol Obstet 1984; 12: 6-22.
11. Hughes G, Bischof P, Wilson G, Smith R, Klopper A. Assay of placental protein to determine fetal risk. Br Med J 1980; 280: 671-3.
12. Toop K, Klopper A. Concentration of pregnancy-associated plasma protein A (PAPP-A) in patients with pre-eclamptic toxaemia. Placenta 1981; 4: 167-74.
13. Westergaard JG, Teisner B. Pregnancy-associated plasma protein A in normal and abnormal late pregnancy. In: Grudzinskas JG, Teisner B, Seppala M, eds. Pregnancy proteins. Sydney: Academic Press, 1982: 345-54.
14. Bersinger NA, Smárason AK, Muttukrishna S, Groome NP, Redman CW. Women with pre-eclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens Preg 2003; 22: 45-55.
15. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87: 1762-7.
16. 1-glycoprotein as a screening test for at-risk pregnancies. Am J Obstet Gynecol 1981; 141: 499-502.
17. Obiekwe BC, Sturdee D, Cockrill BL, Chard T. Human placental lactogen in pre-eclampsia. Br J Obstet Gynaecol 1984; 91: 1077-80.
18. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for preeclampsia. Lancet 1997; 349: 1285-8.
19. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Pre-eclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998; 179: 1539-44.
20. Su YN, Lee CN, Cheng WF, Shau WY, Chow SN, Hsieh FJ. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 2001; 97: 898-904.
21. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J et al. Serum inhibin A and activin A are elevated prior to the onset of preeclampsia. Hum Reprod 2000; 15: 1640-5.
22. Luckas JM, Meekins JW, Walkinshaw SA, McFadyen IR, Neilson JP. Human chorionic gonadotrophin levels between 15 and 17 weeks in women who subsequently develop preeclampsia. Hypertens Preg 1996; 15: 95-100.
23. Luckas JM, Hawe J, Meekins JW, Neilson JP, Walkinshaw SA. Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia. Acta Obstet Gynecol Scand 1998; 77: 381-4.
24. Bakketeig LS, Jacobsen G, Hoffman HJ, Lindmark G, Bergsiø P, Molne K et al. Pre-pregnancy risk factors of small-for-gestational age births among parous women in Scandinavia. Acta Obstet Gynecol Scand 1993; 72: 273-9.
25. Bergsiø P, Hoffman HJ, Davis RO, Goldenberg RL, Lindmark G, Jacobsen G et al. Preliminary results from the collaborative Alabama and Scandinavian study of successive small-for-gestational age births. Acta Obstet Gynecol Scand 1989; 68: 19-25.
26. Marsál K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85: 843-8.
27. Bersinger NA, Zakher A, Huber U, Pescia G, Schneider H. A sensitive immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies. Arch Gynecol Obstet 1995; 256: 185-92.
28. Bersinger NA, Brandenberger AW, Birkhäuser MH. Endometrial and placental protein markers and ovarian steroids in serum during in-vitro fertilisation cycles. Hum Reprod 1995; 10: 2149-54.
29. Malek A, Sager R, Lang AB, Schneider H. Protein transport across the in vitro perfused human placenta. Am J Reprod Immunol 1997; 38: 263-71.
30. Shenhav S, Gemer O, Sassoon E, Volodarsky M, Peled R, Segal S. Mid-trimester triple test levels in early and late onset severe pre-eclampsia. Prenat Diag 2002; 22: 579-82.
31. Wald NJ, Stone R, Cuckle HS, Grudzinskas JG, Barkai G, Brambati B et al. First trimester concentrations of pregnancy-associated plasma protein A and placental protein 14 in Down's syndrome. Br Med J 1992; 305: 28.
32. Aitken DA, McKinnon D, Crossley JA, Graham GW, Berry E, Spencer K et al. Changes in the maternal serum concentrations of PAPP-A and SP1 in Down's syndrome pregnancies between the first and second trimesters. J Med Genet 1994; 31: 170.
33. Bersinger NA, Marguerat P, Pescia G, Schneider H. Pregnancy-associated plasma protein A (PAPP-A): measurement by highly sensitive and specific enzyme immunoassay, importance of first-trimester serum determinations, and stability studies. Reprod Fertil Dev 1995; 7: 1419-23.
34. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997; 18: 657-65.
35. Ahmed A, Dunk C, Ahman S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) and soluble Flt-1 by oxygen - a review. Tropho Res (Placenta) 2000; 14: S16-24.
36. Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab 2000; 13: 343-56.
37. Vatten LJ, Nilsen ST, Odegard RA, Romundstad PR, Austgulen R. Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics 2002; 109: 1131-5.
38. Bersinger NA, Schneider H, Keller PJ. Synthesis of placental proteins by the human placenta perfused in vitro. Gynecol Obstet Invest 1986; 22: 47-51.